Siofor 1000

Quick links to important sections

Siofor 1000

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Siofor 1000

What is Siofor 1000?

Siofor 1000 is an oral medication primarily used to manage blood glucose levels in individuals with type 2 diabetes mellitus. It belongs to a class of drugs known as biguanides, which work by improving the way the body handles insulin without increasing the production of the hormone itself.

Composition and Form

The active ingredient in Siofor 1000 is metformin hydrochloride. Each film-coated tablet contains 1000 mg of this active substance. The tablets are typically white, oblong, and feature a break-line that allows them to be divided into equal halves if necessary.

Mechanism of Action

Siofor 1000 functions through three primary mechanisms to help stabilize blood sugar levels:

  • Reduction of Glucose Production: It limits the amount of glucose (sugar) produced and released by the liver.
  • Improvement of Insulin Sensitivity: It increases the sensitivity of muscle cells to insulin, allowing the body to use existing glucose more effectively.
  • Delay of Glucose Absorption: It slows down the absorption of glucose from the intestines into the bloodstream after eating.

Unlike some other glucose-lowering medications, metformin does not stimulate the pancreas to produce more insulin. Consequently, when used as a standalone treatment, it is associated with a lower risk of causing blood sugar to drop below normal levels.

Therapeutic Purpose

The medication is used when diet and physical exercise alone are insufficient to maintain healthy blood glucose levels. It is frequently prescribed for adults, but it may also be used in children and adolescents under specific clinical guidance. In many cases, it is utilized in patients where weight management is a significant factor in their treatment plan, as it generally does not cause weight gain.

Regulatory References

  1. Metformin - StatPearls - NCBI Bookshelf

What side effects are possible with Siofor 1000?

Possible side effects and safety information

The safety profile of Siofor 1000 (Metformin Hydrochloride) is defined by regulatory documents, which categorize adverse reactions by frequency and physiological system involvement. The information below reflects the official statements from government health authorities like the EMA and FDA.


Adverse Reaction Classification

Classification System-Organ Class Examples of Documented Effects
Very Common (1/10) Gastrointestinal disorders Diarrhoea, nausea, vomiting, abdominal pain, loss of appetite
Common (1/100 to < 1/10) Nervous system disorders Taste disturbance (dysgeusia)
Very Rare (< 1/10,000) Metabolism and nutrition disorders Lactic acidosis, decreased Vitamin B12 absorption
Very Rare (< 1/10,000) Hepatobiliary disorders Abnormal liver function tests, hepatitis

Very Common gastrointestinal effects are frequently observed at the start of therapy and often resolve spontaneously. Conversely, a decrease in Vitamin B12 absorption and corresponding serum levels is a safety pattern associated with long-term exposure.


Serious Adverse Reactions and Safety Constraints

The most serious documented risk is Lactic Acidosis, which is categorized as a Very Rare metabolic complication. This risk is greatly increased by specific pathological states, leading to high-level contraindications in the official labeling. Siofor 1000 is restricted from use in individuals with severe renal impairment (e.g., GFR less than 30 mL/min/1.73 m^2) and conditions causing tissue hypoxia (such as acute heart or respiratory failure), as well as hepatic insufficiency.

Safety notes also emphasize that use in older adults requires closer monitoring of renal function, and the medication must be temporarily discontinued when intravascular iodinated contrast agents are administered.

Overdose and Emergency Response

Overdose Risk and Manifestations

The officially documented risk for Siofor 1000 (Metformin Hydrochloride) overdose centers on the development of lactic acidosis, which is classified by regulatory authorities as a severe, life-threatening metabolic emergency.

Manifestations described in official prescribing information may include nonspecific early signs such as nausea, vomiting, diarrhea, and abdominal pain. Systemic symptoms may progress to somnolence, malaise, and hypothermia, and severe acidosis is typically characterized by an elevated lactate level and respiratory distress. The risk of this severe outcome is officially noted to be significantly increased in individuals with concurrent renal impairment.

Mandatory Emergency Response

Immediate medical attention or emergency measures are strictly mandated upon suspicion or confirmation of overdose. Regulators require hospitalization for all such cases due to the serious nature of the condition.

Official Overdose Statements:

  • The primary, life-threatening manifestation is lactic acidosis.
  • Treatment is symptomatic and supportive, as no specific antidote is known.
  • The essential procedural step for removing accumulated Metformin and correcting acidosis is hemodialysis.

Connection to the overall overdose profile: The regulatory profile explicitly defines overdose by the severe metabolic risk of lactic acidosis and the absence of a known specific antidote. This profile dictates the non-negotiable requirement for immediate medical attention and hospitalization when overdose is suspected.

Therapeutic Uses of Siofor 1000

What Siofor 1000 Treats: Main Uses and Benefits

Siofor 1000 is commonly used as a first-line agent for Type 2 Diabetes Mellitus (T2DM) to manage conditions involving sustained elevation of blood sugar and underlying metabolic imbalance. It is considered relevant in clinical settings that involve chronic glucose regulation issues when diet and exercise alone are insufficient. Its core therapeutic use is to help manage blood sugar levels; it may assist in managing the condition in prediabetic patients and is also applied to address associated metabolic abnormalities in women with Polycystic Ovary Syndrome (PCOS).

The medication generally supports chronic disease management and contributes to easing the overall symptom load by helping to stabilize blood sugar. It may assist with maintaining functional stability regarding weight, which is an important aspect of managing metabolic health.

“It provides support that helps ease the overall symptom burden linked to metabolic imbalance.”

Quick Fact: Relief for Sustained Hyperglycemia

Siofor 1000 is applied in addressing symptom clusters that interfere with daily functioning in conditions characterized by periods of heightened symptoms. This generally contributes to the management of systemic imbalance and supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Siofor 1000

This section details the official population eligibility and non-eligibility rules for Siofor 1000 (Metformin) as strictly defined in governmental regulatory documents.

Category Regulatory Status
Approved Populations Adults ge 18 years of age. Pediatric patients ge 10 years of age with Type 2 Diabetes Mellitus.
Contraindicated Populations (Absolute Ban) Severe Renal Impairment (eGFR < 30 mL/ min/1.73 m^2). Acute Metabolic Acidosis (e.g., lactic acidosis, diabetic ketoacidosis). Hepatic Insufficiency. Acute alcohol intoxication or alcoholism. Hypersensitivity to Metformin.
Condition-Based Restrictions Must be temporarily discontinued before or at the time of procedures involving iodinated contrast media or surgery requiring general anesthesia. Contraindicated in conditions causing tissue hypoxia (e.g., unstable heart failure).
Renal Function Restrictions Use is allowed with specific dose adjustments in patients with moderate renal impairment (eGFR 30-59 mL/ min/1.73 m^2).
Pregnancy/Lactation Status Use is not recommended during breastfeeding. Insulin is often the preferred agent for managing diabetes during pregnancy.

Regulatory documentation strictly defines eligibility, primarily based on the patient's physiological ability to clear the medicine from the body. Treatment is prohibited if severe renal function thresholds are crossed or if the patient is experiencing acute metabolic instability. Furthermore, official labeling advises against its use in patients under 10 years of age and generally recommends careful monitoring for older adults due to the increased likelihood of reduced renal function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Siofor 1000 (metformin hydrochloride) can interact with several other medications, which may affect its efficacy or increase the risk of side effects. It is essential to inform your doctor about all medicines you are taking, including over-the-counter drugs, supplements, and herbal remedies.

Increased Risk of Lactic Acidosis

Co-administration with certain substances can increase the risk of lactic acidosis, a rare but serious side effect of metformin. These include:

  • Contrast agents containing iodine (used in X-ray examinations). Metformin should be temporarily stopped before and after the procedure.
  • Alcohol. Excessive acute or regular alcohol intake significantly increases the risk.
  • Medicines that can impair kidney function, such as some non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or celecoxib, and certain antihypertensives.

Potential for Changes in Blood Sugar Control

Other medications may alter Siofor 1000's effect on blood glucose levels. Your doctor may need to adjust your dose or monitor your blood sugar more frequently if you take:

  • Glucocorticoids (e.g., prednisone) or other medicines that increase blood sugar, such as diuretics (water pills) and some thyroid hormones.
  • Medicines that lower blood sugar, such as sulfonylureas or insulin. This combination may increase the risk of hypoglycemia (low blood sugar).

Table of Key Interactions

Type of Interaction Example Medicines Effect on Siofor 1000 / Patient
Increased Lactic Acidosis Risk Iodinated contrast agents, Excessive alcohol, NSAIDs Requires temporary stop or careful monitoring
Hyperglycemic Effect Glucocorticoids, Diuretics May require increased Siofor 1000 dose
Hypoglycemic Effect Sulfonylureas, Insulin May require reduced Siofor 1000 or accompanying medicine dose

Mechanism of Action

How Siofor 1000 Works: The Mechanism of Action

The action of Metformin Hydrochloride, the active ingredient in Siofor 1000, involves three concurrent physiological modulations arising from a primary influence on cellular energy metabolism. The drug modulates mechanisms associated with glucose metabolism.

1. Inhibiting the Liver's Sugar Output

Metformin's main mechanism begins in the liver where it acts as an inhibitor of Mitochondrial Complex I, altering the cell's energy ratio (AMP:ATP). This change activates the central enzyme AMP-activated protein kinase (AMPK), which in turn suppresses key steps of hepatic gluconeogenesis. This cascade results in a reduction of the liver's release of endogenous glucose into the bloodstream.

2. Increasing Peripheral Tissue Responsiveness

Beyond the liver, Siofor 1000 engages mechanisms that increase the responsiveness to existing insulin in tissues like skeletal muscle. The AMPK activation supports better transport of glucose into these cells, facilitating its utilization. This process influences the regulation of glucose levels in the presence of reduced insulin sensitivity.

3. Modulating Intestinal Glucose Entry

Siofor 1000 also acts locally within the gastrointestinal system to modify nutrient absorption. This mechanism contributes to the total effect by reducing the rate and total amount of glucose that enters the circulation from the gut, influencing postprandial glucose flux.

Dosage and Administration Information

Official Administration of Siofor 1000

Siofor 1000, an immediate-release Metformin Hydrochloride formulation, is approved exclusively for oral administration as a film-coated tablet. Proper use is based on a structured, phased approach that includes specific dosing schedules and administration conditions.


Dosage Regimen and Frequency

Adult Dosing Feature Official Instruction (Immediate-Release Tablets)
Starting Dose 500 mg twice daily or 850 mg once daily.
Maximum Dose 2550 mg per day, taken in divided doses.
Frequency 2 to 3 times daily; doses over 2000 mg are better tolerated when given 3 times daily.

The dosage is gradually increased from the starting dose in increments, such as 500 mg weekly, based on tolerability, until the effective or maximum daily dose is reached. If a dose is missed, it should be skipped, and the patient should resume the usual dosing schedule with the next planned dose; taking two doses at once is not recommended.


Administration Conditions and Population Rules

Metformin tablets must be swallowed whole with liquid and should be taken with or immediately after meals to improve gastrointestinal tolerability. The drug's use is subject to mandatory constraints related to kidney function, which is assessed using the estimated Glomerular Filtration Rate (eGFR):

  • Renal Function: Use is contraindicated if eGFR is below 30 mL/ min/ 1.73 m^2. Initiation is not recommended if eGFR is between 30 and 45 mL/ min/ 1.73 m^2.
  • Pediatric Use: The tablets are approved for use in children 10 years of age and older, with a maximum recommended daily dose of 2000 mg.
  • Procedural Suspension: The medication must be temporarily discontinued at the time of, or prior to, any iodinated contrast imaging procedure for specific patient groups and withheld for 48 hours afterward until renal function is confirmed as stable.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Siofor 1000


Evidence for Managing Type 2 Diabetes Mellitus (T2DM)

The research foundation for the active ingredient in Siofor 1000, Metformin, is extensive. It includes numerous Randomized Controlled Trials (RCTs), along with comprehensive Systematic Reviews and long-running Observational Follow-up Studies. This body of research has been primarily used to explore how the compound was evaluated in adults with Type 2 Diabetes.

Studies have primarily monitored changes in key outcomes related to blood sugar control. Research explored levels of HbA1 c and Fasting Plasma Glucose levels. Findings reported how these biomarkers evolved in the observed populations. Other long-term studies examined outcomes related to systemic or functional imbalance, specifically looking at patterns related to major cardiovascular events (MI, stroke), and monitoring long-term changes in body weight or Body Mass Index (BMI).

However, certainty remains low in some areas. Data for certain groups, particularly very frail or older adult subgroups with complex health issues, remain insufficient for establishing consistent findings. Additionally, comparative evidence is lacking regarding long-term cardiovascular outcomes against some newer treatments. Research is ongoing to provide insight into these comparative areas.


️ Evidence for Prediabetes and Delaying T2DM Diagnosis

Siofor 1000's active ingredient was studied for its application in individuals identified as high-risk for developing Type 2 Diabetes, a state known as prediabetes. This evidence comes from foundational, long-term Randomized Controlled Trials and their subsequent long-term observational follow-up studies.

These studies primarily monitored the main outcome related to the rate of conversion from prediabetes to a formal T2DM diagnosis over a period of many years. Research highlights changes measured during the study period, with findings describing patterns observed in the studies related to the rate of T2DM diagnosis among participants compared to the control group.

It is not yet clear whether the observed pattern persists once the medicine is stopped; research describes that the measured change was not maintained after discontinuation. Furthermore, the evidence contributes to understanding symptom patterns and conversion rates, but there is limited information for long-term outcomes related to major heart or circulation issues in this prediabetic population.


‍️ Evidence for Metabolic Abnormalities in Polycystic Ovary Syndrome (PCOS)

Siofor 1000 was evaluated in women and adolescents diagnosed with Polycystic Ovary Syndrome (PCOS). Studies primarily explored outcomes related to systemic or functional imbalance, such as insulin sensitivity (HOMA-IR) and fasting insulin levels. Research also examined how symptoms evolved in the observed populations, particularly monitoring reproductive markers such as the regularity of the menstrual cycle and rates of ovulation.


⏳ Long-Term Research and Durability of Study Findings

The evidence base includes research from Randomized Controlled Trials (RCTs) and their observational extensions that was observed in participants over defined time intervals spanning many years, with some studies reaching follow-up durations of over a decade. The data show patterns related to how key outcomes like blood sugar stability and the measured incidence of major complications evolved over this time.


What Is Still Uncertain About the Research for Siofor 1000

  • Comparative evidence is lacking for certain outcomes when comparing Siofor 1000 against some of the very newest classes of diabetes and metabolic medicines.
  • Follow-up durations were limited in many studies focusing on specific indications like PCOS, meaning the long-term effects are not fully established for those uses.
  • Subgroup findings are uncertain for many specialized populations, including people with certain types of complex, coexisting health conditions or very advanced age groups. The results apply only to the populations studied in the research.

Key Studies & References

  1. Diabetes Prevention Program Outcomes Study (DPPOS) - ClinicalTrials.gov
  2. Metformin - StatPearls - NCBI Bookshelf
  3. Metformin in polycystic ovary syndrome: systematic review and meta-analysis
  4. NICE Advice on Polycystic ovary syndrome: metformin in women not planning pregnancy

Frequently Asked Questions (FAQ)

Common questions about Siofor 1000 (FAQ)

Q: What is the main purpose of Siofor 1000?

A: Official prescribing information states that Siofor (metformin) is used along with diet and exercise to help improve glycemic control, which means managing blood sugar levels, in people with Type 2 Diabetes Mellitus.

Q: Is Siofor 1000 the same as generic Metformin?

A: Siofor 1000 is a brand-name formulation that contains the active substance, Metformin Hydrochloride. Various commercial products containing this substance are available, often referred to as generic metformin.

Q: What is the difference between Siofor 1000 and Siofor XR 1000?

A: Siofor 1000 is an immediate-release tablet, meaning the active substance is released into the body relatively quickly. Siofor XR refers to extended-release formulations, which are designed to release the medication more slowly over a longer period.

Q: What class of drug does Siofor 1000 belong to?

A: The active substance in Siofor, metformin, belongs to a group of oral anti-diabetic medications known as biguanides. This classification is based on how the medicine works in the body to help lower blood sugar.

Q: Can Siofor 1000 be used by people who are not overweight?

A: The official indication for Siofor is to improve blood sugar control in people with Type 2 Diabetes Mellitus. The use of this medication is based on a diagnosis of diabetes and is not restricted only to patients who are overweight.

Q: Is Siofor 1000 used for Type 1 diabetes or only Type 2 diabetes?

A: Siofor is officially indicated for the treatment of Type 2 Diabetes Mellitus only. It is not indicated for the management of Type 1 Diabetes Mellitus.

Q: How quickly does Siofor 1000 start to affect blood sugar levels?

A: Based on pharmacokinetics, the drug reaches its peak concentration in the bloodstream a few hours after administration. However, achieving the full and stable blood sugar-lowering effect typically requires consistent use over several days or weeks.

Q: How long does it usually take to see the full effect of Siofor 1000?

A: Official data indicates that it may take approximately two weeks for the full clinical effect to be fully apparent. Dosage adjustments are typically gradual, and maximal benefit is generally observed after a stable dose has been maintained for several weeks.

Q: Are gastrointestinal issues like diarrhea and nausea common when starting Siofor 1000?

A: Yes, gastrointestinal side effects such as diarrhea, nausea, vomiting, abdominal pain, and loss of appetite are described in official documents as being very common (affecting more than 1 in 10 people). These issues are most likely to occur when treatment is first started.

Q: How long do the common side effects of Siofor 1000 typically last?

A: Official guidance states that common gastrointestinal side effects are often transient, meaning they tend to decrease and disappear over the course of ongoing treatment. Taking the medication with meals is a recognized measure intended to help improve tolerability.

Q: Does Siofor 1000 cause weight loss?

A: Clinical studies often report that metformin is associated with either a neutral effect or slight weight loss. When compared to some other diabetes medications that can cause weight gain, metformin is generally not associated with weight increase.

Q: Does Siofor 1000 cause low blood sugar (hypoglycemia) on its own?

A: Official information indicates that Siofor (metformin) used as a single agent (monotherapy) does not typically cause low blood sugar (hypoglycemia). However, a risk of low blood sugar is associated with its use in combination with other anti-diabetic medications like insulin or sulfonylureas.

Q: What is Lactic Acidosis and what is its relationship to Siofor 1000?

A: Lactic Acidosis is a very rare but serious medical complication that can occur with metformin use. It involves the buildup of lactate (lactic acid) in the blood and is typically associated with pre-existing conditions like severe kidney problems. Regulatory documents include a prominent warning about this risk.

Q: Are there certain medical conditions that would prevent someone from taking Siofor 1000?

A: Yes, regulatory documents list specific conditions that are considered contraindications for Siofor. These include severe kidney impairment, any acute condition that may cause tissue hypoxia (low oxygen), acute alcohol intoxication, and a history of certain types of metabolic acidosis.

Q: Is a metallic taste in the mouth a known side effect of Siofor 1000?

A: Yes, a change in taste described as a metallic taste (dysgeusia) is listed in official prescribing information as a common side effect of metformin.

Q: Can Siofor 1000 be taken with other oral diabetes medicines?

A: Yes, Siofor is often used as a single medication, but official indications also include its use in combination with other oral anti-diabetic agents or with insulin when combination therapy is required.

Q: What is the risk of taking Siofor 1000 with alcohol?

A: Official sources warn against excessive alcohol intake while taking Siofor. Alcohol can significantly increase the risk of developing Lactic Acidosis, especially when consumption is heavy or if combined with fasting.

Q: Is there a known interaction between Siofor 1000 and X-ray dyes (contrast agents)?

A: Yes, the use of X-ray dyes (iodinated contrast agents) for radiological procedures can temporarily increase the risk of Lactic Acidosis. Official instructions generally require that Siofor be temporarily stopped before or during the procedure and resumed only after kidney function has been checked.

Q: Does Siofor 1000 interact with common over-the-counter medicines?

A: Official labeling details interactions with various prescription drug classes, such as certain diuretics (water pills) and blood pressure medicines, especially those that affect the kidneys. Patients should review all concomitant medications, including over-the-counter products, with their medical provider.

Q: Does Siofor 1000 affect vitamin B12 levels in the body?

A: Yes, official safety information indicates that long-term use of metformin is associated with a decrease in vitamin B12 levels. Periodic monitoring of vitamin B12 is often recommended to check for deficiency, which could lead to anemia.

Q: Can Siofor 1000 cause skin reactions like rashes or itching?

A: Skin reactions, including hives (urticaria), redness (erythema), and itching (pruritus), are listed in official documents as very rare side effects of metformin (affecting less than 1 in 10,000 people).

Q: Is it safe to stop taking Siofor 1000 suddenly?

A: Siofor is used for continuous control of blood sugar, and abrupt cessation without a planned transition may lead to a rise in blood glucose levels. Discontinuation should be managed under the direction of a healthcare professional.

Q: Can Siofor 1000 be used during pregnancy or while breastfeeding?

A: Metformin use during pregnancy involves a careful medical assessment of the benefits and risks. For breastfeeding, official documents state the active substance passes into breast milk in small amounts, and medical guidance is needed to determine the appropriate course of action.

Q: Can children or adolescents use Siofor 1000?

A: Yes, Siofor (metformin) is indicated for use in children and adolescents 10 years of age and older who have been diagnosed with Type 2 Diabetes Mellitus.

Q: Does Siofor 1000 interact with blood pressure medications?

A: Official information advises caution when Siofor is used with certain types of blood pressure medications, such as those that might affect kidney function (like ACE inhibitors or diuretics). This is because changes in kidney function can increase the risk of Lactic Acidosis.

Q: Does Siofor 1000 have any long-term health benefits described in studies?

A: Clinical studies have shown that metformin is effective at improving blood sugar control. Long-term research has also examined the drug's effects on potentially reducing diabetes-related complications, such as cardiovascular events.

Q: What is the recommended storage temperature for Siofor 1000?

A: Official regulatory information specifies that Siofor 1000 tablets should generally be stored at room temperature (e.g., 20 C to 25 C). It should be kept protected from excessive moisture and heat.

Q: Is Siofor 1000 approved for use in patients with insulin resistance who do not have Type 2 diabetes?

A: The regulatory indication is strictly to improve glycemic control in patients with Type 2 Diabetes Mellitus. Use for other conditions, such as non-diabetic insulin resistance, is not authorized by the drug label and is considered outside its official scope.

Q: What types of food should be avoided while taking Siofor 1000?

A: Official documents stress avoiding excessive alcohol consumption due to its link with increased risk of Lactic Acidosis. While the drug is advised to be taken with food, there are generally no specific restrictions on other food types.

Q: Can Siofor 1000 make existing digestive conditions worse?

A: The drug's most common side effects are gastrointestinal, including diarrhea and nausea. While Siofor is advised to be taken with meals to improve its gastrointestinal tolerability, these common side effects could be more pronounced if a patient has pre-existing digestive conditions.

Q: Does Siofor 1000 interact with herbal supplements?

A: Due to the potential for interactions, official medical guidance recommends that patients always inform their healthcare provider of all concomitant products, including herbal supplements, before taking Siofor 1000.

Q: Is it safe to drive or operate machinery while taking Siofor 1000?

A: When Siofor is used alone, it is generally unlikely to affect the ability to drive or operate machinery because it does not usually cause low blood sugar. However, if Siofor is combined with other medications that can cause hypoglycemia (like insulin), caution is advised.

Q: Is Siofor 1000 known to cause tiredness or fatigue?

A: Tiredness or fatigue is not typically listed as a common direct side effect. However, symptoms of the rare but serious complication, Lactic Acidosis, can include unusual malaise and severe tiredness, which should be reported promptly.

Q: Can Siofor 1000 be used in combination with insulin?

A: Yes, regulatory documents indicate Siofor (metformin) can be used alongside insulin when diet, exercise, and metformin alone do not achieve sufficient control over blood sugar levels.

Q: What is the significance of the 1000 mg strength of Siofor?

A: The 1000 mg strength is simply one of the available forms of the tablet. It allows for flexible dosing and is often used to help patients achieve the required daily amount or to reduce the overall number of tablets that need to be taken.

Q: Are there other names for Siofor 1000 in different countries?

A: Yes, while the active substance remains Metformin Hydrochloride, it is marketed under many different brand names across the world, such as Glucophage, Formet, and others, depending on the country or region.

Q: How does Siofor 1000 help the body use insulin?

A: Siofor is considered an insulin sensitizer. Its primary mechanisms include improving insulin sensitivity in muscles and other tissues and decreasing the amount of glucose produced by the liver.

Q: Can Siofor 1000 cause changes in vision?

A: Changes in vision are not typically listed as a common direct side effect. However, patients with diabetes can experience temporary vision changes due to unstable blood sugar levels, and any concerning visual symptoms should be reported.

Q: Is it possible to have an allergic reaction to Siofor 1000?

A: Yes, official labeling states that Siofor is contraindicated in any patient with a known hypersensitivity (allergic reaction) to metformin hydrochloride or to any of the non-active ingredients used in the tablet formulation.

Q: What are the signs that Siofor 1000 is working?

A: Siofor is considered effective when it helps to improve glycemic control. This improvement is medically assessed by monitoring laboratory values such as the HbA1 c level (a measure of average blood sugar over time), fasting blood glucose, and post-meal glucose levels.

Q: Is Siofor 1000 ever used for Polycystic Ovary Syndrome (PCOS)?

A: The authorized regulatory indication for Siofor is exclusively for Type 2 Diabetes Mellitus. While metformin is sometimes discussed in relation to conditions like Polycystic Ovary Syndrome (PCOS), this use is considered off-label and is not supported by the drug’s official labeling.

Q: Does Siofor 1000 affect the liver?

A: Siofor's primary mechanism of action involves reducing glucose production in the liver. Official guidance emphasizes monitoring of kidney function, and liver function is often checked during treatment. The drug is contraindicated in severe metabolic acidosis, which can be associated with liver dysfunction.

Q: Can Siofor 1000 be used by the elderly?

A: Siofor may be used in the elderly population. However, dosage requires careful assessment based on regular monitoring of renal function to manage safety considerations, as reduced kidney function is more common with age.

Q: Are there any restrictions on physical activity while taking Siofor 1000?

A: Siofor is indicated for use alongside diet and exercise. Generally, physical activity is encouraged, but intense exercise that could lead to severe dehydration or low oxygen states is a topic that warrants discussion with a medical provider.

Q: Can Siofor 1000 cause hair loss?

A: Hair loss is not listed as a common or uncommon side effect in official prescribing information. Changes in hair may sometimes be related to underlying diabetic conditions or the drug's documented effect on vitamin B12 levels.

Q: Why is Siofor 1000 not recommended for people with severe infection?

A: Official safety warnings state that Siofor is not recommended during states associated with hypoxia (low oxygen), such as severe acute infection or shock. These conditions increase the risk of Lactic Acidosis, and symptoms of this complication are considered serious and should be reported promptly.

Q: Does Siofor 1000 affect cholesterol levels?

A: Siofor’s primary action is on blood sugar control. Clinical data generally suggests that metformin has a neutral or positive effect on lipid parameters (cholesterol and triglycerides) in people with Type 2 Diabetes.

Q: What part of the body does Siofor 1000 primarily affect?

A: The drug primarily affects three areas: the liver (to reduce glucose production), the intestines (to decrease glucose absorption), and the muscles/tissues (to improve the body's response to insulin).

Q: How is Siofor 1000 different from sulfonylurea type diabetes medicines?

A: Siofor, a biguanide, works mainly by reducing glucose production in the liver and making tissues more sensitive to insulin. In contrast, sulfonylureas primarily work by stimulating the pancreas to release more insulin into the bloodstream.

Q: Why is it important to have regular blood tests while taking Siofor 1000?

A: Regulatory documents stress the importance of regular blood tests to check renal function ( eGFR), which is critical for assessing the risk of Lactic Acidosis, and to check vitamin B12 levels, which may be affected by long-term use.

Q: Is the color or shape of the Siofor 1000 tablet significant?

A: The physical characteristics of the tablet, such as its shape, color, and any unique markings, serve as important tools for the manufacturer for product identification and quality assurance. The film-coated tablets must be swallowed whole to ensure proper release of the medication.

How should Siofor 1000 be stored and disposed of?

Storage and Disposal of Siofor 1000

The official storage and disposal guidelines for Siofor 1000 (Metformin Hydrochloride) are defined by regulatory labeling to ensure product quality and public safety.


Storage Requirements

Siofor 1000 tablets must be stored at Controlled Room Temperature, typically 20°C to 25°C (68°F to 77°F). The product must be kept in a tight, light-resistant container and stored away from heat, moisture, and direct light.

It is mandatory to Keep from freezing.

Child Safety and Disposal

For safety, the medicine must be kept strictly out of the reach of children.

Unused or expired Siofor 1000 must not be discarded into household waste or wastewater. Final disposal must be performed in accordance with local requirements, and consultation with a healthcare professional regarding proper disposal methods is required.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Siofor 1000 found in:

A-Z Index: